European Companies Search Engine
EU funding (€2,812,437): A PeRsOnalized Prevention roadmap for the future HEalThcare Hor26 Aug 2022 EU Research and Innovation programme "Horizon"
Overview
Text
A PeRsOnalized Prevention roadmap for the future HEalThcare
"""PROPHET - a PeRsOnalized Prevention roadmap for the future HEalThcare"" will develop a Strategic Research and Innovation Agenda (SRIA) for Personalized Prevention, in order to support the implementation of innovative, sustainable and effective personalized programmes to prevent common chronic diseases. Technological biomedical advances (including omics data and digital tools) make risk stratification at the individual level possible. However, development of Personalized Prevention approaches must be accompanied by healthcare system transition, including citizen engagement, healthcare professional education and addressing organisational, social and legal issues. PROPHET will be centred around stakeholder engagement and the SRIA co-creation process in relation to three main strands of activities: Mapping, Assessment, and Building. Firstly, we will summarize, evaluate and discuss with the relevant stakeholders the extent to which all these new technologies can synergise (Mapping). Secondly, we will design a holistic framework (the PROPHET Framework) that will include all the necessary aspects to appraise Personalized Prevention approaches and their adoption by Public Health Authorities (Assessment). Thirdly, we will support the introduction of Personalised Prevention Programmes by providing guidelines for their design, engaging with healthcare professionals (especially those working with policy makers), and increasing health literacy at the population level on the benefits of Personalized Prevention (Building). PROPHET will liaise with other key current and forthcoming initiatives at EU level, such as ICPerMed, European Partnership (EP) PerMed, the CSA Beyond 1 Million Genomes (B1MG), and the EP on Transforming Health and Care Systems. The consortium consists of 18 beneficiaries and 2 affiliated entities across 12 EU Countries, and a large number of stakeholders already engaged from different Target Groups."
Funded Companies:
| Company name | Funding amount |
| Foundation for Genomics & Population Health | ? |
| Allelica Srl | €35,500 |
| ASS Cittadinanzattiva ApS | €86,875 |
| Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) | €84,812 |
| Consorcio Centro de Investigacion Biomedica en Red M.P | €263,460 |
| Debreceni Egyetem | €45,875 |
| EUROPEAN MOLECULAR BIOLOGY LABORATORY | €124,625 |
| EUROPEAN PUBLIC HEALTH Association | €80,975 |
| Fondazione Policlinico Universitario Agostino Gemelli Irccs | €0.00 |
| Forum des Patients Europeens | €98,750 |
| GAC | €284,025 |
| HELSINGIN YLIOPISTO | €85,811 |
| Instituto de Salud Carlos III | €0.00 |
| Instituto Nacional de Saude DR. Ricardo Jorge | €173,125 |
| Karolinska Institutet | €197,375 |
| Katholieke Universiteit Leuven | €159,500 |
| STICHTING AMSTERDAM UMC | €186,250 |
| TARTU ULIKOOL | €155,000 |
| TERVEYDEN JA HYVINVOINNIN LAITOS | €175,064 |
| Universita Cattolica Del Sacro Cuore | €451,415 |
| Universiteit Gent | €25,670 |
| UNIVERSITEIT VAN AMSTERDAM | €98,330 |
Source: https://cordis.europa.eu/project/id/101057721
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Foundation for Genomics & Population Health, Cambridge.
The visualizations for "Foundation for Genomics & Population Health - EU funding (€2,812,437): A PeRsOnalized Prevention roadmap for the future HEalThcare"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
